Oculus Innovative Sciences Reports Financial Results for Fiscal Year 2016 and Fourth Quarter Ending March 31, 2016
Product Revenue for Fiscal Year 2016 Grew 31% Led by Growth in U.S. Dermatology Conference Call Begins at 4:30pm EDT Today PETALUMA, Calif., June 16, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty …